DrugPatentWatch Database Preview

Details for Patent: 7,838,027

« Back to Dashboard

Which drugs does patent 7,838,027 protect, and when does it expire?

Patent 7,838,027 protects PROTONIX and is included in one NDA.

Protection for PROTONIX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-four patent family members in twenty-seven countries.

Summary for Patent: 7,838,027

Title:	Pantoprazole multiparticulate formulations
Abstract:	Pantoprazole sodium multiparticulates are described which avoid sticking to nasogastric and gastronomy tubes. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof, or a salt thereof, a surfactant, and a disintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose (hypromellose) and water, an enteric coat on the sub-coat, and a final seal coat over the enteric coat, which is composed of hydroxypropyl methylcellulose (hypromellose) and water.
Inventor(s):	Venkata Ramana Rao; Sripriya (Iselin, NJ), Shah; Syed M. (East Hanover, NJ), Tatapudy; Hanumantharao (Suffern, NY), Saunders; Richard William (Palisades, NY), Fawzi; Mahdi (Morristown, NJ), Nagi; Arwinder (Thiells, NY), Singh; Shailesh (Bardonia, NY), Hasan; Sumon A. (Monroe, NY)
Assignee:	Wyeth LLC (Madison, NJ)
Application Number:	10/574,210
Patent Claim Types: see list of patent claims	Compound; Dosage form; Use; Formulation;

Drugs Protected by US Patent 7,838,027

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Wyeth Pharms Inc	PROTONIX	pantoprazole sodium	FOR SUSPENSION, DELAYED RELEASE;ORAL	022020-001	Nov 14, 2007		RX	Yes	Yes					Y

Foreign Priority and PCT Information for Patent: 7,838,027

PCT Information
PCT Filed	September 30, 2004	PCT Application Number:	PCT/US2004/033058
PCT Publication Date:	April 14, 2005	PCT Publication Number:	WO2005/032513

Non-Orange Book US Patents Family Members for Patent 7,838,027

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,544,370	Pantoprazole multiparticulate formulations
7,553,498	Pantoprazole multiparticulate formulations
7,550,153	Pantoprazole multiparticulate formulations

International Family Members for US Patent 7,838,027

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	045956
Australia	2004278037
Brazil	PI0415014
Canada	2539982